Literature DB >> 9849518

Hormone replacement therapy and cardioprotection in the elderly.

A Pines1, H Kessel, V Mijatovic, M J van der Mooren.   

Abstract

Mesh：

Year:  1998        PMID： 9849518      PMCID： PMC1296875          DOI： 10.1177/014107689809100906

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  25 in total

1.  Postmenopausal use of estrogen and occlusion of coronary arteries.

Authors:  H W Gruchow; A J Anderson; J J Barboriak; K A Sobocinski
Journal:  Am Heart J       Date:  1988-05       Impact factor: 4.749

2.  Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.

Authors:  L Mosca; J E Manson; S E Sutherland; R D Langer; T Manolio; E Barrett-Connor
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

Review 3.  The primary prevention of coronary heart disease in women.

Authors:  J W Rich-Edwards; J E Manson; C H Hennekens; J E Buring
Journal:  N Engl J Med       Date:  1995-06-29       Impact factor: 91.245

4.  Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group.

Authors:  T A Manolio; C D Furberg; L Shemanski; B M Psaty; D H O'Leary; R P Tracy; T L Bush
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

5.  Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women.

Authors:  J M Sullivan; R Vander Zwaag; J P Hughes; V Maddock; F W Kroetz; K B Ramanathan; D M Mirvis
Journal:  Arch Intern Med       Date:  1990-12

6.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors:  T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

7.  Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women.

Authors:  M K Hong; P A Romm; K Reagan; C E Green; C E Rackley
Journal:  Am J Cardiol       Date:  1992-01-15       Impact factor: 2.778

8.  The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.

Authors:  M Falkeborn; I Persson; H O Adami; R Bergström; E Eaker; H Lithell; R Mohsen; T Naessén
Journal:  Br J Obstet Gynaecol       Date:  1992-10

9.  17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease.

Authors:  P Collins; G M Rosano; P M Sarrel; L Ulrich; S Adamopoulos; C M Beale; J G McNeill; P A Poole-Wilson
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

10.  The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

Authors:  B M Psaty; S R Heckbert; D Atkins; R Lemaitre; T D Koepsell; P W Wahl; D S Siscovick; E H Wagner
Journal:  Arch Intern Med       Date:  1994-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.